Disulfiram Side Effects and Safety Profile
Most Critical Safety Concern: Hepatotoxicity
Disulfiram carries a significant risk of severe and sometimes fatal hepatotoxicity, which is the primary reason it is now rarely used and contraindicated in patients with any degree of liver disease. 1
Hepatic Toxicity Details
- Fatal hepatitis occurs in approximately 1 in 30,000 patients treated per year, though severe hepatotoxicity requiring transplantation or resulting in death has been documented even after many months of therapy 2, 1
- Hepatotoxicity is an idiosyncratic reaction that can develop at any time during treatment, regardless of prior liver function status 1, 3
- Absolute contraindication in patients with alcoholic liver disease, acute hepatitis, elevated liver enzymes, or any hepatic cirrhosis/insufficiency 1, 3, 4
- Patients must immediately report early hepatitis symptoms: fatigue, weakness, malaise, anorexia, nausea, vomiting, jaundice, or dark urine 1
- Baseline and follow-up liver function tests at 10-14 day intervals are required to detect hepatic dysfunction 1
Disulfiram-Alcohol Reaction
Cardiovascular Effects
- Flushing, throbbing in head and neck, chest pain, palpitations 1, 4
- Tachycardia, hypotension, syncope 1
- Severe reactions: cardiovascular collapse, arrhythmias, myocardial infarction, acute congestive heart failure 1, 2
Gastrointestinal Effects
Neurological Effects
- Throbbing headache, dizziness, vertigo, blurred vision, confusion 1, 4
- Marked uneasiness, weakness 1
- Severe reactions: unconsciousness, convulsions, death 1
Respiratory Effects
Reaction Characteristics
- Reactions can occur with alcohol up to 14 days after last disulfiram dose 1
- Mild reactions occur at blood alcohol levels as low as 5-10 mg/dL in sensitive individuals 1
- Symptoms fully developed at 50 mg/dL; unconsciousness typically at 125-150 mg/dL 1
- Duration: 30-60 minutes in mild cases, several hours in severe cases, or as long as alcohol remains in blood 1
- Deaths from disulfiram-alcohol reactions are now rare, likely due to lower dosing (250-500 mg/day vs historical higher doses) and exclusion of cardiac patients 2, 5
Central Nervous System Toxicity (Direct Drug Effect)
Psychiatric and Neurological Effects
- Psychotic reactions, acute organic brain syndrome, confusional states, catatonia 6, 2
- Peripheral neuropathy and optic neuritis (dose-related) 2
- Psychiatric complications appear more common in Indian populations than Western countries 2
- Risk increased with: excessive dosing, pre-existing major psychiatric illness, or anatomical brain lesions 6
- CNS toxicity typically appears in first weeks of treatment and reverses after drug discontinuation 6
Mechanism of CNS Effects
- Disulfiram and its metabolite carbon disulfide inhibit dopamine beta-hydroxylase, increasing dopamine and reducing norepinephrine levels in the CNS 6, 7
- Brain catecholamine effects occur at doses higher than those inhibiting aldehyde dehydrogenase, suggesting therapeutic dosing (25 mg/kg or lower equivalent) may avoid neurotoxicity while maintaining efficacy 7
Common Non-Serious Side Effects
- Tiredness, headache, sleepiness are most frequent 2
- Rubber contact dermatitis (hypersensitivity to thiuram derivatives) - patients with this history should be evaluated before receiving disulfiram 1
Important Drug Interactions and Precautions
- Interactions with cytochrome P450 enzyme system compounds 2
- Should not be exposed to ethylene dibromide or its vapors - animal research suggests toxic interaction with higher tumor incidence and mortality 1
- Use with extreme caution in: diabetes mellitus, hypothyroidism, epilepsy, cerebral damage, chronic/acute nephritis 1
Clinical Efficacy Context
Despite these risks, disulfiram has poor evidence for efficacy - systematic reviews conclude there is little evidence it enhances abstinence, and its use has been largely supplanted by safer alternatives like acamprosate and naltrexone 8
Safer Alternative Medications
For Patients WITH Liver Disease:
- Acamprosate is the preferred agent - no hepatic metabolism, no hepatotoxicity risk, safe in liver disease 3, 9, 4
- Baclofen may be used in cirrhosis - doses up to 80 mg/day generally safe, though gradual titration recommended in severe liver disease 3, 4
- Naltrexone is contraindicated - causes hepatocellular injury 8, 3, 4
For Patients WITHOUT Liver Disease:
- Acamprosate - most evidence for maintaining abstinence (odds ratio 1.49), requires prior detoxification 8, 9
- Naltrexone - moderate evidence for efficacy (odds ratio 0.70 for dropout reduction) 8
Critical Patient Education Requirements
Patients must carry identification cards stating they are on disulfiram and describing reaction symptoms, with emergency contact information 1
Patients must be warned to avoid alcohol in all forms:
Never administer disulfiram to intoxicated patients or without their full knowledge 1